Long-Term Prognosis Of Patients With Empty Sella Syndrome
Published on: September 8, 2025
Long-Term Prognosis of Patients with Empty Sella Syndrome featured image
Article author photo

Sai Suprajaa

Bachelor of Science in Biomedical Science

Article reviewer photo

Daisy Porter

BSc Biotechnology and Microbiology, University of York

What is Empty Sella Syndrome?

There are two types of empty sellas: primary empty sella (PES), which happens without a clear precipitating event, and secondary empty sella (SES), which develops as a result of pituitary injury or shrinkage caused by events like postpartum hemorrhage, pituitary surgery, irradiation, apoplexy, infection, head trauma, or lymphocytic hypophysitis. An empty sella is a scan finding in which the sella turcica (a bony cavity at the base of the skull) appears enlarged and is partially or completely filled with cerebrospinal fluid, causing the pituitary gland to look flattened against its walls.

Pathophysiology and Causes

The radiologic finding of an empty sella is often discovered by accident. Cerebrospinal fluid (CSF) can move into the sella turcica due to weakness of the diaphragm sellae, flattening the pituitary gland and enlarging the bony structure. Empty sella syndrome (ESS), the condition linked to this finding, might present with symptoms like headache and vision problems.

Primary empty sella (PES) and secondary empty sella (SES) are the two main categories into which ESS falls. PES is thought to be idiopathic (without a known cause). On the other hand, SES develops after acquired disorders such as trauma, surgery, radiation, infection, or postpartum pituitary necrosis that directly reduce pituitary volume.

PES is less common, and a little is known about its development. A number of mechanisms have been proposed:

  • Congenital diaphragm sellae defects: Pituitary gland remodeling, hypertrophy, and compression result from CSF entering the sella due to incompetent or missing diaphragm sellae
  • Chronic intracranial hypertension: High brain pressure can encourage CSF herniation into the sella, especially when the diaphragm sellae is already weak. Empty sella is commonly seen in idiopathic intracranial hypertension (pseudotumor cerebri), and this can reverse with treatment
  • Pituitary volume fluctuations: Temporary gland enlargement followed by shrinkage can leave space for CSF to enter. Examples can include pituitary growth during pregnancy and breastfeeding, followed by shrinkage after menopause

SES usually occurs when the pituitary is directly injured. Surgical removal or radiation therapy for pituitary tumors, shrinking from medication, autoimmune inflammation, or spontaneous damage and death of gland tissue are common causes.2

Symptoms of Empty Sella Syndrome

Empty sella syndrome (ESS) is often symptom-free and identified by chance during brain scans for unrelated causes.

When symptoms appear, they are often grouped into two types: 

  • Neurologic symptoms: Headache is the most common and can be mild or severe. Visual problems, such as blurred vision or loss of part of the visual field, can be brought on by high brain pressure or compression of the optic chiasm
  • Endocrine symptoms: Some people may develop partial or full pituitary hormone deficiencies. Symptoms can include erectile dysfunction, irregular or absent menstruation, infertility, low energy, and reduced libido. In rare cases, milk production (galactorrhea) may result from high prolactin levels

Overall, most people with ESS remain without symptoms. Although it is more frequently linked to SES than PES, significant hormone problems are uncommon.3,4

Diagnostic Approach and Treatment Options

The diagnosis of empty sella syndrome (ESS) is usually accidental, identified during imaging for other reasons, with magnetic resonance imaging (MRI) being the preferred test. The pituitary gland appears flattened against the sellar floor with cerebrospinal fluid around it.

Not all patients with ESS need treatment. If pituitary function is unaffected, therapy is not required. In symptomatic situations management becomes important.

The main treatment is hormone replacement medication to correct deficiencies, such as hydrocortisone for adrenal insufficiency, levothyroxine for central hypothyroidism, and dopamine agonists for high prolactin. In some cases, sex hormone or growth hormone replacement may also be considered. In extreme situations with vision loss or fluid leaks, surgical procedures may be necessary, while treatments like weight loss or certain medications can help if brain pressure is high. To maximize quality of life, ongoing follow-ups with specialists is recommended.5

Long-Term Prognosis of Empty Sella Syndrome

Predominantly, empty sella syndrome (ESS) has a good long-term prognosis. Large studies show that while some individuals may have pituitary hormone deficiencies at first, worsening over time is rare. Most patients in long-term studies remained stable, with only a small number developing additional hormone deficiencies. This shows that ESS typically follows a benign course.

However, the outlook can vary. Compared to people with primary ESS, those with secondary ESS may be more likely to develop further hormone issues. Conditions like obesity, high blood pressure, and idiopathic intracranial hypertension can also contribute to long-term problems.

In general, ESS is usually a chronic but stable condition that needs monitoring rather than aggressive treatment. Patients with ESS need tailored follow-up treatment to make sure that any related neurological issues or minor hormone problems are managed.6,7

Risk and Complications

ESS is linked to a number of risks and complications. Among the most commonly reported are hormone deficiencies. Research suggests that up to 40–50% of patients with primary empty sella may have at least one pituitary hormone shortage at the time of diagnosis, with growth hormone and reproductive hormones being the most affected. In certain cases, multiple hormone systems may be involved.

Even though new hormone deficiencies rarely appear over time, the initial load of hormone problems may have a significant impact on health. Since the risks differ depending on whether ESS is accidental or symptomatic, these issues highlight the importance of long-term monitoring.8

Lifestyle monitoring and Long - term management

Lifestyle changes are especially important for patients with chronic brain pressure problems and obesity, among other linked conditions. Losing weight and keeping a healthy body mass index (BMI) can help lower intracranial pressure, which reduces symptoms like headaches and vision changes. Healthy eating and regular physical activity may also lower cardiovascular risks linked to hormone problems. Patients are also encouraged to avoid risk factors like smoking, uncontrolled blood pressure, and a sedentary lifestyle.

When hormone replacement therapy is needed, it must be adjusted on an ongoing basis to prevent both under and over treatment. Long-term care should also include patient education, (ensuring that people understand the importance of following treatment plans) recognizing warning signs like vision changes, and knowing when extra precautions are needed for conditions like adrenal insufficiency.

Lifestyle care should include both physical health and emotional wellbeing. The best way to maintain quality of life and reduce the risk of long-term issues is multidisciplinary follow-ups with endocrinologists, neurologists, ophthalmologists, and primary care physicians.9

Summary

In summary, Empty Sella Syndrome (ESS) is a disorder in which the pituitary gland is flattened within the sella turcica, a small bony hole in the skull that is partially filled with cerebrospinal fluid. There are two basic types: secondary empty sella (SES), which is caused by pituitary gland shrinkage or injury following events such as surgery, radiation, trauma, or problems during childbirth, and primary empty sella (PES), which develops for no apparent reason. Many ESS instances are discovered during brain scans for other purposes because the disorder is frequently asymptomatic and silent.

When symptoms do appear, they usually fall into one of two categories: endocrine or neurologic. Neurologic symptoms, such as headaches or visual issues including blurred vision or partial loss of visual fields, are associated with variations in brain pressure. Pituitary hormone deficits (endocrine) can result in menstruation abnormalities, infertility, low energy, erectile dysfunction, or decreased libido.

MRI scans, which display the flattened pituitary encircled by fluid, are typically used to confirm the diagnosis, yet not every patient needs medical attention. If hormone shortages are identified, replacement medications such as hydrocortisone, thyroid hormone, or sex hormones can help restore balance. It may be necessary to have surgery in cases of significant eyesight loss or cerebrospinal fluid leakage. Reducing weight and taking some medications can also help patients with elevated blood pressure.

According to studies, the majority of people don't change over time, and very few get new hormone shortages. While secondary ESS may be more susceptible to hormonal problems because of its underlying causes, primary ESS is frequently benign.

Long-term care relies heavily on lifestyle control techniques. Better results are supported by avoiding smoking, regulating blood pressure, maintaining an active lifestyle, and maintaining a healthy weight. Any alterations will be identified early thanks to ongoing monitoring by specialists like neurologists, endocrinologists, and eye doctors. Most people with ESS lead full, healthy, and satisfying lives if they receive the right care and receive regular follow-up.

References

  1. Miljic D, Pekic S, Popovic V. Empty sella [Internet]. Endotext - NCBI Bookshelf. 2024. Available from: https://www.ncbi.nlm.nih.gov/sites/books/NBK532084/
  2. Ucciferro P, Anastasopoulou C. Empty Sella syndrome [Internet]. StatPearls - NCBI Bookshelf. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK541002/
  3. Rice-Canetto TE, Carroll P, Reier L, Siddiqi J. Asymptomatic Empty SELLA: A Literature review and suggestions for Evaluation in Clinical practice. Cureus [Internet]. 2024 Dec 18; Available from: https://pubmed.ncbi.nlm.nih.gov/39834994/
  4. Sorrentino FP, Chiloiro S, Giampietro A, Bianchi A, Pontecorvi A, De Marinis L. Empty sella syndrome: an update. Pituitary [Internet]. 2024 Dec 30;28(1). Available from: https://pubmed.ncbi.nlm.nih.gov/39738761/
  5. Lundholm MD, Yogi-Morren D. A comprehensive review of Empty Sella and Empty Sella syndrome. Endocrine Practice [Internet]. 2024 Mar 12;30(5):497–502. Available from: https://doi.org/10.1016/j.eprac.2024.03.004
  6. Steckel L, Gizewski ER, Kaser S. Pituitary function in patients with primary and secondary empty sella. Frontiers in Endocrinology [Internet]. 2025 Jul 16;16. Available from: https://doi.org/10.3389/fendo.2025.1632824
  7. Chiloiro S, Giampietro A, Bianchi A, Tartaglione T, Capobianco A, Anile C, et al. DIAGNOSIS OF ENDOCRINE DISEASE: Primary empty sella: a comprehensive review. European Journal of Endocrinology [Internet]. 2017 Aug 6;177(6):R275–85. Available from: https://doi.org/10.1530/eje-17-0505
  8. Carosi G, Brunetti A, Mangone A, Baldelli R, Tresoldi A, Del Sindaco G, et al. A multicenter cohort study in patients with primary empty SELLA: Hormonal and Neuroradiological Features over a Long Follow-Up. Frontiers in Endocrinology [Internet]. 2022 Jun 23;13. Available from: https://doi.org/10.3389/fendo.2022.925378
  9. Admin, Admin. Effective empty Sella Syndrome treatment Options [Internet]. Acibadem Health Point - ACIBADEM Hospitals - Acibadem Health Group. 2024. Available from: https://www.acibademhealthpoint.com/effective-empty-sella-syndrome-treatment-options
Share

Sai Suprajaa

Bachelor of Science in Biomedical Science

arrow-right